Thrivent Financial for Lutherans
Position in ENTA — Enanta Pharmaceuticals Inc
CIK 314984
Minneapolis, MN
Position in ENTA
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$358,387
-$89,102 QoQ
Shares Held
28,376
0.0% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Thrivent Financial for Lutherans holds $270,833,554 across 48 Biotechnology names. ENTA ranks #44 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
1,568,627 | $67,278,411 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
627,699 | $35,458,716 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
75,977 | $33,926,767 | |
| 4 | RPRX |
Royalty Pharma plc
|
499,167 | $23,945,040 | |
| 5 | TECH |
BIO-TECHNE Corp
|
302,934 | $15,831,330 | |
| 6 | ARGX |
Argenx SE
|
12,682 | $9,261,030 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
20,470 | $6,772,908 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,440 | $6,521,080 |
All Filings in ENTA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $358,387 | 28,376 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $447,489 | 28,376 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $407,470 | 34,041 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $648,904 | 85,834 | Shares | Defined | 2025-08-26 | |
| 2025-03-31 | $473,803 | 85,834 | Shares | Defined | 2025-08-26 | |
| 2024-12-31 | $253,586 | 44,102 | Shares | Defined | 2025-02-10 | |
| 2023-12-31 | $98,428 | 10,460 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $122,724 | 10,987 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,081,919 | 50,557 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,861,857 | 46,040 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $929,609 | 19,983 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,044,558 | 20,138 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $856,106 | 18,111 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $1,057,592 | 14,858 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,094,928 | 14,642 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $826,187 | 14,543 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $646,638 | 14,693 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $727,371 | 14,748 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $622,743 | 14,792 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $678,139 | 14,813 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $680,948 | 13,562 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $688,699 | 13,391 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||